Also, increaseddifucosylated N-glycans, containing both core andantennary fucose, could be a more reliable indicator of recurrentbreast cancer because it was proved to outperform currently used breastcancer biomarkers, such as carcinoembryonic antigen (CEA), CA 15–3,and CA 125. This evidence concerns the gene CEACAM5 and cancer.